Leinco Technologies and Vanderbilt University Medical Center have agreed to scale up production of the latter's antibodies with the most potential to develop an immunodiagnostic test to detect SARS-CoV-2. No financial details of the deal were disclosed.
Partnership to develop SARS-CoV-2 immunodiagnostic test
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.